Drug-induced rotational behaviour following unilateral intracerebral injection of saline-ascorbate solution: neurotoxicity of ascorbic acid and monoamine-independent circling.
D015116:5,7-Dihydroxytryptamine / Q000494:pharmacology*; D008735:5-Methoxytryptamine / Q000494:pharmacology*; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000633:toxicity*; D001519:Behavior / Q000187:drug effects*; D002540:Cerebral Cortex / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism; D004102:Dihydroxytryptamines / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D006892:Hydroxydopamines / Q000494:pharmacology*; D008297:Male; D008474:Medial Forebrain Bundle / Q000187:drug effects; D009043:Motor Activity / Q000187:drug effects*; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D012965:Sodium Chloride / Q000633:toxicity*; D013239:Stereotyped Behavior / Q000187:drug effects*; D014363:Tryptamines / Q000494:pharmacology*; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D004102:Dihydroxytryptamines; D006892:Hydroxydopamines; D014363:Tryptamines; D015116:5,7-Dihydroxytryptamine; D012701:Serotonin; D008735:5-Methoxytryptamine; D012965:Sodium Chloride; D005680:gamma-Aminobutyric Acid; D001058:Apomorphine; D001205:Ascorbic Acid; D004298:Dopamine; D009638:Norepinephrine